Generics acquisition announced

Amneal Pharmaceuticals has announced it will acquire all of Actavis Australia's in-country generic pharmaceuticals business.  

The two companies today announced they have signed a binding letter of intent providing for the deal to go ahead for an agreed price, subject to completion of confirmatory due diligence and definitive agreements.

Financial terms of the agreement are not available, the two companies said in a release, however "both sides have agreed to work expeditiously to complete the transaction with the goal of preventing